Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 425
Selected: 0
NCT IDTitle
NCT00022620Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer
NCT00498953Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx
NCT00068757Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
NCT04065165Lanreotide Combined With Telotristat Ethyl or Placebo for the First-line Treatment in Patients With Advanced Well Differentiated Small Intestinal Neuroendocrine Tumours (siNET) With Highly-functioning Carcinoid Syndrome
NCT00014300Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme
NCT00003267Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer
NCT00002623Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
NCT03294746Imaging Biomarker in Cancer Drug Induced ILD
NCT04708548Long Term Implications of Rare Brain Tumours'
NCT00002895Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer
NCT00006357STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma
NCT00005868Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer
NCT01788982Nintedanib(BIBF1120) in Thyroid Cancer
NCT03673735Maintenance Immune Check-point Inhibitor Following Post-operative Chemo-radiation in Subjects With HPV-negative HNSCC
NCT00014326Involved-Field Radiation Therapy in Treating Patients With Previously Untreated Stage I or Stage II Low-Grade Non-Hodgkin's Lymphoma
NCT00074087Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides
NCT05065346Neoadjuvant DaRT for Locally Advanced Oral Cavity SCC
NCT00005062Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission
NCT00849082Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer
NCT07234877Phase II Study of Upfront SRT Plus Ivonescimab/Chemotherapy vs Ivonescimab/Chemotherapy in NSCLC Brain Mets
NCT00077116Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome
NCT07425808FLT3-ITD Targeted Therapy in Fit AML Patients
NCT00003062Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer
NCT03134118Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM)
NCT00027677Halofuginone Hydrobromide in Treating Patients With Progressive Advanced Solid Tumors
NCT00064207Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer
NCT00060385Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma
NCT00017108Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic Leukemia
NCT00074074Infliximab in Treating Patients With Myelodysplastic Syndrome
NCT00014625E7070 in Treating Patients With Stage IV Melanoma
NCT03235245Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimetinib
NCT03784066Durvalumab With or Without Tremelimumab in Resectable Locally Advanced Squamous Cell Carcinoma of the Oral Cavity
NCT00002851Lymph Node Radiation Therapy in Patients With Stage I, Stage II, or Stage III Breast Cancer That Has Been Surgically Removed
NCT02365441A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST)
NCT03260712Pembrolizumab in Biliary Tract Cancer
NCT02982694Study With Atezolizumab Plus Bevacizumab in Patients With Chemotherapy Resistant, MSI-like, Colorectal Cancer
NCT01101425Male Breast Cancer: Understanding the Biology for Improved Patient Care
NCT00003985KRN7000 in Treating Patients With Solid Tumors
NCT03224104Multi-kinase Inhibitor TG02 (TG02) in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma.
NCT03319316Combination of Durvalumab and Tremelimumab as Maintenance Treatment in Patients With Non Squamous and Squamous (NSCLC)
NCT06326190177Lu-DOTATATE for Recurrent Meningioma
NCT00003014Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer
NCT01288378Empirical Versus Preemptive Antifungal Therapy
NCT00006351SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract
NCT00081237OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal Cancer
NCT05815927Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer
NCT00028743Combination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
NCT03005015Lenvatinib in Second Line Endometrial Carcinoma
NCT02799706Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer
NCT06978062Peri-operative Treatment of Resectable Gastroesophageal Cancer Using Bemarituzumab (BEMA) Plus Perioperative Treatment